[go: up one dir, main page]

DK1766003T3 - Thrombinpræparater - Google Patents

Thrombinpræparater

Info

Publication number
DK1766003T3
DK1766003T3 DK05766031T DK05766031T DK1766003T3 DK 1766003 T3 DK1766003 T3 DK 1766003T3 DK 05766031 T DK05766031 T DK 05766031T DK 05766031 T DK05766031 T DK 05766031T DK 1766003 T3 DK1766003 T3 DK 1766003T3
Authority
DK
Denmark
Prior art keywords
thrombin
thrombin preparations
cacl2
mannitol
nacl
Prior art date
Application number
DK05766031T
Other languages
Danish (da)
English (en)
Inventor
Shan Jiang
Richard I Senderoff
Jeffrey D Meyer
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1766003T3 publication Critical patent/DK1766003T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK05766031T 2004-06-22 2005-06-21 Thrombinpræparater DK1766003T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58182404P 2004-06-22 2004-06-22
PCT/US2005/021743 WO2006009989A1 (en) 2004-06-22 2005-06-21 Thrombin compositions

Publications (1)

Publication Number Publication Date
DK1766003T3 true DK1766003T3 (da) 2008-12-08

Family

ID=34981715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05766031T DK1766003T3 (da) 2004-06-22 2005-06-21 Thrombinpræparater

Country Status (11)

Country Link
US (2) US7393674B2 (de)
EP (1) EP1766003B1 (de)
JP (1) JP4767253B2 (de)
AT (1) ATE405643T1 (de)
AU (2) AU2005265251B2 (de)
CA (1) CA2570478C (de)
DE (1) DE602005009191D1 (de)
DK (1) DK1766003T3 (de)
ES (2) ES2395466T3 (de)
IL (1) IL179852A0 (de)
WO (1) WO2006009989A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE405643T1 (de) * 2004-06-22 2008-09-15 Zymogenetics Inc Thrombinzusammensetzungen
US8233963B2 (en) 2007-02-19 2012-07-31 Medtronic Navigation, Inc. Automatic identification of tracked surgical devices using an electromagnetic localization system
EP2167041B1 (de) * 2007-06-15 2012-11-07 Zymogenetics, Inc. Stabilisierte Thrombinzusammensetzungen
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
JP5437236B2 (ja) * 2008-04-16 2014-03-12 一般財団法人化学及血清療法研究所 トロンビン固定化生体吸収性シート製剤の製造方法
EP2113564A1 (de) * 2008-05-01 2009-11-04 Arecor Limited Proteinformulierung
AU2011260274B2 (en) 2010-06-01 2015-07-02 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
AU2011260260B2 (en) * 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
US20130096479A1 (en) * 2011-10-18 2013-04-18 St. Teresa Medical, Inc. Method of forming hemostatic products
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
US9149529B2 (en) 2012-10-24 2015-10-06 Orthovita, Inc. Stable compositions containing thrombin and methods for preparation and use thereof
US9212357B2 (en) * 2012-12-03 2015-12-15 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
CN104274827B (zh) * 2013-07-01 2020-07-14 上海贺普药业股份有限公司 贺普拉肽的制剂
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
WO2016112026A1 (en) * 2015-01-06 2016-07-14 St. Teresa Medical, Inc. Hemostatic products
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
CA3004272C (en) 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
CA3004734A1 (en) 2015-11-12 2017-06-18 St. Teresa Medical, Inc. A method of sealing a durotomy
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition
IL261190A (en) * 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363319A (en) 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
US4696812A (en) 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
JPS63243032A (ja) 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
JPS6440433A (en) 1987-08-05 1989-02-10 Green Cross Corp Aqueous liquid composition of thrombin
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
ES2131504T3 (es) 1990-02-20 1999-08-01 Baxter Int Trombina humana purificada viricamente segura.
JPH0813750B2 (ja) 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
DE69122376D1 (de) 1991-03-28 1996-10-31 Warner Lambert Co Hochreine Thrombinzubereitung
CA2175203A1 (en) 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
RU2136319C1 (ru) 1993-12-23 1999-09-10 Джонсон энд Джонсон Медикал, Инк. Биоабсорбируемое хирургическое гемостатическое средство и способ его получения (варианты)
EP0993311B1 (de) 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Thrombin und mikrofibrillares collagen enthaltene zusammensetzung sowie herstellungsmethoden und dessen gebrauch
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
US5981254A (en) 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
EP1221479B1 (de) 1999-09-27 2006-11-22 Sysmex Corporation Verfahren zur stabilisierung von thrombin
AU1071701A (en) * 1999-09-29 2001-04-30 Trustees Of The University Of Pennsylvania, The Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor
US20050232899A1 (en) 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
ATE405643T1 (de) 2004-06-22 2008-09-15 Zymogenetics Inc Thrombinzusammensetzungen

Also Published As

Publication number Publication date
EP1766003B1 (de) 2008-08-20
AU2005265251B2 (en) 2009-09-10
US20060002918A1 (en) 2006-01-05
AU2009238369A1 (en) 2009-12-10
CA2570478C (en) 2011-08-23
IL179852A0 (en) 2007-05-15
ES2395466T3 (es) 2013-02-12
CA2570478A1 (en) 2006-01-26
US7393674B2 (en) 2008-07-01
ES2313383T3 (es) 2009-03-01
JP4767253B2 (ja) 2011-09-07
JP2008503240A (ja) 2008-02-07
AU2009238369B2 (en) 2012-05-24
DE602005009191D1 (de) 2008-10-02
AU2005265251A1 (en) 2006-01-26
WO2006009989A1 (en) 2006-01-26
US7473543B2 (en) 2009-01-06
EP1766003A1 (de) 2007-03-28
ATE405643T1 (de) 2008-09-15
US20070104705A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
IL179852A0 (en) Thrombin compositions
MY142354A (en) Acidic insulin preparations having improved stability
NZ593190A (en) Factor viii formulations
MY129417A (en) Zinc-free and low-zinc insulin preparations having improved stability
WO2007019232A3 (en) Immunoconjugate formulations
CA2634663A1 (en) Novel albumin-free factor viii formulations
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
TR200002299T2 (tr) Epotilon kompozisyonları.
CY1108547T1 (el) Αναλογα σωματοστατινης
ATE246202T1 (de) Gcsf konjugate
HK1104212A1 (en) Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2008011559A3 (en) Synthetic lung surfactant and use thereof
WO2004029095A3 (en) Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof
WO2008060934A3 (en) Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
WO2006097943A3 (en) Pharmaceutical compositions of amlodipine and benazepril
DE60009529D1 (de) Pharmazeutische zusammensetzung aus fibrinolytischem mittel
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
WO2003086272A3 (en) Ultrapure transferrin for pharmaceutical compositions
MEP20408A (en) Pharmaceutical dronedarone composition for parenteral administration
NO20065791L (no) Asyklovir-formuleringer
IL155788A (en) A highly purified ifn – β active and mannitol-containing preparation, a method to make an improved stability of ifn – β active, and a method to enhance the stability of ifn – β in biologically active formulation.
CA2528988A1 (en) Stable, aqueous solution of human erythropoietin, not containing serum albumin
EA201070766A1 (ru) Стабильные при комнатной температуре лиофилизированные композиции натрийуретического пептида